Search Results 61-70 of 16138 for pharmacogenetics

  1. Impact of Pharmacogenomic Testing in the Management of Chronic Pain in Children - Mayo Clinic

    The purpose of this study is to: Assess outcome differences in two groups of pediatric patients with chronic pain. Review the perceived effectiveness and ...

  2. PGY-2 Pharmacy Residency in Clinical Pharmacogenomics at Mayo Clinic - Department and Faculty

    Learn about the department and faculty of the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.

  3. Pharmacogenomics: RIGHT 10K Study - Center for Individualized Medicine - Mayo Clinic Research

    In the Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment (RIGHT 10K) Study, Mayo Clinic collaborated with Baylor College of ...

  4. A Study to Evaluate the Pharmacist Role and Pharmacogenomics in the Care of Seriously Ill Patients - Mayo Clinic

    About this study · The impact that a clinical pharmacist and pharmacogenomic testing has on symptom management; · Patient perceptions, satisfaction and behaviors ...

  5. A Study to Evaluate Precision Pharmacogenomics in Cancer Patients - Mayo Clinic

    THe purpose of this study is to examine the current and (potential) future therapeutic relevance of pharmacogenomics (PGx) testing for a cohort of cancer ...

  6. Genetic-guided testing for blood thinner drugs offers patients individualized treatment - Mayo Clinic

    The American Heart Association gives guidance on CYP2C19 genetic-guided testing for prescribing blood thinner drugs. A Mayo Clinic cardiologist chaired the ...

  7. Treatment-resistant depression - Mayo Clinic

    Consider pharmacogenetic testing. These tests check for specific genes ... Currently, pharmacogenetics tests are not a sure way to show if a medication ...

  8. Genetic Testing Clinical Trials - Mayo Clinic Research

    Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...

  9. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

    ... pharmacogenetics component of this study. Refusal to give consent for this component does not exclude a participant from participation in this clinical ...

  10. Publications - Loralie J. Langman, Ph.D. - Mayo Clinic

    Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. ... Pharmacogenetic workup of ...